Rocket Lab Fell 54% in Seven Weeks. Here's the Math on Whether $40 Is Next.
Rocket Lab closed at $68.50 today, down 54% from its May high. If $40 is the number you have circled as your entry, here is the actual math on whether that price is coming, and whether it would actually be a good idea to buy it when it does.
The short version: $40 is a real level, but the timing is not there yet. It is not a number pulled out of thin air. It sits close to where this stock already traded eight months ago, before the whole run to $150. But the stock is not oversold yet, so here is the full calculation, not just the conclusion.
The business, plainly
Rocket Lab builds and launches rockets. Electron flies today. Neutron, the medium-lift one, is still in testing. It increasingly builds satellites and spacecraft components for other people's missions too. Q1 2026 revenue: $200.3 million, up 63.5% year over year. Backlog: $2.2 billion, up 108%. Gross margin: 38.2%.
It is also still losing money. Net loss $45 million in the quarter, adjusted EBITDA negative $11.8 million. Growth this fast, from a company this young, at this margin, is genuinely rare. It is not yet the ROIC compounder that Netflix or TSMC are. Judge it on a different scale.
Why it fell 54% in seven weeks
Three real things stacked on top of each other.
Rocket Lab agreed to buy Iridium, the satellite operator, for about $8 billion: $54 a share in cash and stock. Deutsche Bank and Wells Fargo committed a $3.6 billion bridge loan for the cash piece. More debt and new shares are still coming for the rest. That is leverage and dilution, on top of a company that already burns cash, decided while the stock was already volatile.
Piper Sandler then initiated coverage at Neutral with an $83 target, built off 39 times projected 2027 revenue. Their call: the valuation premium over SpaceX is too rich for the risk. The same week, CEO Peter Beck and other insiders sold stock. None of that is a lie about the business. It is the market pricing in real integration risk on a real deal.
And Neutron, the rocket the whole growth story leans on, has slipped three times now. First "end of 2025." Then "early 2026." Now "no earlier than Q4 2026," after a fuel tank ruptured in testing this January. Three slips in a row has the burnt smell of a program still finding its footing, not a scandal, but it is not free of cost either. A team can out-execute one delay. A third one earns skepticism, not benefit of the doubt.
The honest counter-argument
None of that erases what Rocket Lab actually has. It is one of exactly two Western companies anyone takes seriously for medium-lift launch, and the other one is SpaceX. That backlog is real contracted revenue, not a hope. Iridium adds a 66-satellite constellation and a recurring connectivity revenue stream on top of lumpy launch and hardware sales, if the integration goes even reasonably well.
A stock does not fall 54% because the story broke. It falls that hard because a very optimistic price met three real risks at once. The combination left a bitter aftertaste that no single risk would have caused alone. That gap between "risky" and "broken" is exactly where the next move gets decided.
Five scenarios, 3 years out
| Scenario | Price target | Move from $68.50 | What has to happen |
|---|---|---|---|
| Super Bull | $210 | +207% | Neutron flies clean in 2027, Iridium integrates smoothly, national security launch contracts scale hard, the market re-rates Rocket Lab as the number two space-infrastructure prime after SpaceX. |
| Bull | $130 | +90% | Matches today's high sell-side targets (Citi, Morgan Stanley, Citizens, Roth). Neutron flies with only modest further slippage, Iridium dilution lands in line with guidance, growth holds near 40-50% a year. |
| Base | $83 | +21% | Piper Sandler's own number: Neutron flies in 2027, Iridium closes with real but manageable dilution, growth decelerates toward the 30-35% a year the Street already models. |
| Bear | $45 | -34% | Neutron slips a fourth time, Iridium integration runs messier and more dilutive than guided, growth decelerates faster than the base case. |
| Super Bear | $25 | -64% | Another Neutron test failure or a multi-year slip, the Iridium deal strains the balance sheet into a forced dilutive raise, national security orders slow. |
I built this off Rocket Lab's own reported numbers and Piper Sandler's published methodology, not a full sell-side consensus. A $40 entry sits almost exactly between the Bear and Super Bear cases above. It is only 55 cents below the $39.48 this stock actually traded at eight months ago. That is not a wild number. It is a retest of the floor this stock stood on before the entire run to $150.
The expected return, honestly
Weight those five scenarios at 8%, 27%, 35%, 22% and 8%. That is a much wider spread on both ends than the Netflix table I built two days ago.
Do that math and the probability-weighted return lands close to 10 to 11% a year over three years, with no dividend. Almost the same number as Netflix. The difference is not the destination. It is how wide the road is on either side of it: Netflix's worst case was a mature media multiple. Rocket Lab's worst case is a forced dilutive raise on a cash-burning balance sheet. Same expected return, a far wider distribution. That changes how big a position this should ever be, even at the right price.
What the RSI actually says, and when to act
Weekly RSI is 43.6. Daily RSI is 32.1, down hard the last two weeks but not below 30 yet. Neither reading says oversold. By the house rule, that means no entry signal today, at $68.50 or anywhere near it.
The pace, run honestly: this stock has fallen at roughly 10.2% a week since the May 27 peak, and it has held that pace for seven straight weeks. Extend that same rate forward and $40 arrives in about five weeks. That is an honest read of the current trend, not a promise the trend continues in a straight line. Selloffs this sharp usually either snap back or accelerate into a real washout. Q2 earnings land August 6, almost exactly inside that five-week window, and will move the number either way.
So here is the straight answer. $40 is a real, defensible level, not a number pulled from the pace alone. That does not mean today is the day to buy. Watch for weekly RSI to actually cross below 30. A move into the $40s would very likely produce that reading, given how sharp this decline already is. August 6 earnings matter too, before sizing anything.
One more thing worth saying plainly. Even at a great price, this does not belong in the Compounding Portfolio next to Netflix or TSMC. Negative ROIC, active dilution, a rocket that has slipped three times. That combination is a moonshot-bucket position, sized small, not a core holding, no matter how cheap it gets.
Cheap and broken sounds identical to cheap and temporarily out of favor for the first few weeks. It takes an earnings call to tell the two apart, and this one lands August 6.
Watching a falling stock for the moment it stops falling takes the same patience as watching a real launch. Most of the drama is in the seconds you are told to just wait. Building that discipline, waiting for your own number instead of the one the headlines hand you, is exactly what I built the Compounding Portfolio system inside the Sprint Club to do: strategysprints.com
Ready to accelerate now? Book a Discovery Call: calendly.com/strategysprint/discovery-call
Happy hunting.
Simon & The Sprinters 🐬⚡️🐆
Get our expert sales tips delivered
By submitting you agree to receive our weekly Strategy Sprints Newsletter as well as other promotional emails from Strategy Sprints. You may withdraw your consent at any time via the “Unsubscribe” link in any email or view our privacy policy at ant time.
